Profound Medical (PROF) Net Income towards Common Stockholders (2024 - 2026)
Profound Medical (PROF) posted quarterly Net Income towards Common Stockholders of $7.1 million for Q1 2026, down 34.23% year-over-year from $10.7 million in Q1 2025, and down 90.84% quarter-over-quarter from $77.0 million in Q4 2025.
Profound Medical (PROF) Net Income towards Common Stockholders (2024 - 2026) Analysis & Trends
Profound Medical's Net Income towards Common Stockholders history runs 3 years deep, the most recent figure standing at $7.1 million for Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders fell 34.23% year-over-year to $7.1 million; the TTM figure through Mar 2026 stood at $60.3 million (up 33.73% YoY), while the FY2025 annual figure was $42.6 million, up 53.04% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at $7.1 million, down from $77.0 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $77.0 million in Q4 2025, with the low at -$15.7 million in Q2 2025.
- The 3-year median for Net Income towards Common Stockholders is -$6.6 million (2024), against an average of $11.0 million.
- Peak annual rise in Net Income towards Common Stockholders reached 262.85% in 2025, while the deepest fall reached 126.84% in 2025.
- Profound Medical's Net Income towards Common Stockholders stood at $50.7 million in 2024, then soared by 51.85% to $77.0 million in 2025, then slumped by 90.84% to $7.1 million in 2026.
- Business Quant data shows PROF's Net Income towards Common Stockholders at $7.1 million in Q1 2026, $77.0 million in Q4 2025, and -$8.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.60 Bn | 194.00 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.14 Bn | 123.66 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.89 Bn | 109.67 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.11 Bn | 72.57 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 52.03 Bn | 47.78 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.31 Bn | 32.36 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Profound Medical | 245.37 Mn | 207.10 Mn | 1.95 Mn | -9.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.54 Mn |
| Mar 31, 2026 | 7.05 Mn |
| Dec 31, 2025 | 76.97 Mn |
| Sep 30, 2025 | -7.98 Mn |
| Jun 30, 2025 | -15.70 Mn |
| Mar 31, 2025 | 10.72 Mn |
| Dec 31, 2024 | 50.69 Mn |
| Sep 30, 2024 | -9.37 Mn |
| Jun 30, 2024 | -6.92 Mn |
| Mar 31, 2024 | -6.59 Mn |